Noninvasive Prenatal Screening

March 12, 2019

Noninvasive Prenatal Screening

Summary

The conference about modern noninvasive screening of fetal aneuploidy in pregnant women has been successfully finished. We enjoyed this meeting and thank both the participants and speakers. According to the feedback of the participants they are also very pleased with the event.

Over 70 medical specialists were registered for the conference as participants from several Georgian cities. The main focus of the conference was on noninvasive prenatal testing for aneuploidies using high throughput sequencing, specifically about Ionatest – the only CE IVD NIPT test now available in Georgia.

You may enjoy the foto gallery on our FB page

Introduction

Noninvasive prenatal testing using only blood of the pregnant women is a new and very precise method to detect the main chromosome pathologies and sex of the fetus early in pregnancy. It's popularity is rapidly growing worldwide. It provides many benefits for doctors and their patients. At the conference "Noninvasive prenatal screening 2019" you will know about the technology and results of its implementation in clinical practice. We'll also demonstrate you that this wonderful possibility is now available and affordable in Georgia.

Important information for the participants

- Venue: D. Aghmashenebeli Alley #240, Tbilisi; the campus of the Free University, Conference room #200

- Date: March 12, 2019

- Working language: English

Registration fee is 35 GEL and includes:

access to the lectures

participant package

- a bage

- a program

- a paper notebook

- a pen

- a mousepad

- an information booklet

- a certificate of the participant

- and 2 wonderful coffee breakes with the best opportunity for networking with colleagues

This event is available only after registration.

Invited speakers

Stephen Little, PhD

Stephen is a successful serial biotechnology entrepreneur. He is the former CEO of DxS, an innovator in the field of personalised medicine, developing and manufacturing companion diagnostics. DxS pioneered the use of molecular diagnostic tests such as KRAS and EGFR mutation analysis to predict the use of novel cancer therapies. In 2009 Stephen became Vice President of Personalised Healthcare, responsible for developing companion diagnostic partnerships with the pharma industry. Prior to his leading role at DxS, Stephen worked for 20 years in various senior positions in the diagnostic divisions of Astra Zeneca and ICI. He holds a PhD from Heriot-Watt University in Edinburgh.

Maka Chipashvili, MD, PhD

Clinical geneticist "Perinatology"

Zaza Sinauridze, MD, PhD

Obstetrician-Gynicologist, Chairman of the "Perinatology" NLLE, Clinical Director "Pineo Medical Ecosystem"

Alexander Lavrov , MD, PhD

Head of The National Laboratory of Genetics

Program

15:00 - 16:00	Registration of the participants and welcome coffee with networking
16:00 - 16:05	Opening and introduction	G. Chaladze
16:05 - 16:25	Possibilities and perspectives of prenatal screening in Georgia	M. Chipashvili
16:25 - 16:45	Prenatal diagnostics: summary of the results and new challanges	Z. Sinauridze
16:45 - 17:25	NIPT: basics of technology	S. Little
17:25 - 17:50	Coffee pause and networking
17:50 - 18:30	NIPT: Iona experience in clinical practice	S. Little
18:30 - 18:50	Molecular genetics in reproduction: new Georgian horizons	A. Lavrov
18:50 - 19:00	Closing

Organizers

National Laboratory of Genetics is the only laboratory in Georgia providing molecular genetic testing of the human hereditary diseases.

Our aims:

to develop and establish the best practices in molecular diagnostics of hereditary and oncologic diseases.
to help doctors and their patients to benefit from modern personalized medicine based on the knowledge of molecular basis of diseases.
to educate doctors and patients about modern technologies of diagnostics and prevention of orphan diseases.

Contacts

D. Aghmashenebeli Alley #240

Tbilisi, Georgia

+ 995 32 2 052 888

Contacting person: Medea Zhvania